Pinguecula
Evidence-based assessment and management of conjunctival elastotic degeneration. Comprehensive guide covering etiology, pathogenesis, classification, UV-related risk, pingueculitis, and treatment protocols for optometry practice.
Last updated: March 2026
Quiescent pinguecula — yellowish-white elevated conjunctival deposit at the nasal limbus within the interpalpebral fissure; minimal surrounding vascular injection
Pingueculitis — acute inflammation of a pre-existing pinguecula with marked perilesional conjunctival injection and localised oedema; triggered by UV exposure, desiccation, or irritants
A pinguecula (plural: pingueculae; from the Latin pinguis, meaning fat or grease) is a common, benign, non-neoplastic, yellowish-white elevated deposit of degenerative conjunctival tissue located in the bulbar conjunctiva within the interpalpebral fissure — characteristically on the nasal side, though temporal pingueculae also occur. It represents elastotic degeneration of the subepithelial collagenous stroma, driven primarily by cumulative ultraviolet (UV) irradiation.
Pingueculae are among the most prevalent external ocular conditions globally, with epidemiological studies in tropical and subtropical regions — including Singapore — reporting prevalence rates exceeding 70% in adults over 50 years of age. Despite being overwhelmingly benign and asymptomatic in the majority of cases, pingueculae are clinically significant for several reasons: they can induce tear film instability and ocular surface disease; they may become acutely inflamed (pingueculitis); they serve as a marker of cumulative UV exposure and ocular surface vulnerability; and they require careful differentiation from potentially pre-malignant conjunctival lesions such as conjunctival intraepithelial neoplasia (CIN).
A key anatomical distinction separates pinguecula from pterygium: pinguecula does not encroach upon or invade the cornea. The lesion remains confined to the conjunctiva, nasal or temporal to the limbus, without corneal tissue invasion.
Pinguecula formation is multifactorial, with UV radiation as the dominant environmental driver. The condition represents a degenerative — not inflammatory or neoplastic — response of the conjunctival stroma to chronic actinically induced damage.
Primary Etiological Factors
- Ultraviolet radiation (UV-B and UV-A) — the principal etiological driver. The interpalpebral zone receives the greatest UV exposure due to the optical geometry of the cornea; UV light is focused by the corneal tear film onto the nasal limbal conjunctiva (limbal focusing effect), explaining the nasal predominance of pingueculae. UV-B (290–320 nm) is particularly damaging to stromal collagen and induces elastotic degeneration via direct DNA damage and upregulation of matrix metalloproteinases (MMPs)
- Chronic ocular surface desiccation and dry eye — reduced tear film protection exposes the conjunctival epithelium and stroma to osmotic stress and inflammatory mediators, accelerating elastotic change
- Wind and dust exposure — particulate and aerosol deposition on the ocular surface causes chronic mechanical irritation; occupational and outdoor exposure amplifies risk
- Age-related connective tissue degeneration — progressive accumulation of elastotic material reflects the normal ageing of subepithelial conjunctival collagen; prevalence increases substantially with advancing age
Contributing and Modifying Factors
- Geographic latitude — higher UV index in tropical and subtropical regions correlates with greater prevalence and earlier onset; Singapore, located at 1.3°N, has among the highest global UV indices year-round
- Occupational and recreational outdoor exposure — farming, fishing, construction, and military occupations; outdoor sports without UV-protective eyewear
- Contact lens wear — mechanical irritation, reduced oxygen transmissibility, and tear film disruption may contribute
- Smoke exposure — cigarette smoke and environmental smoke contain oxidative compounds that potentiate ocular surface damage
- Genetic predisposition — some individuals with lighter irides and less melanin-based UV protection may be at higher risk, though the genetic contribution remains incompletely characterised
The pathogenesis of pinguecula centres on UV-induced elastotic degeneration of the subepithelial conjunctival stroma — specifically the Bowman-equivalent zone and superficial stroma — through several interconnected mechanisms.
Elastotic degeneration (solar elastosis) — repeated UV irradiation alters the normal collagen (predominantly types I and III) of the substantia propria. Fibroblasts respond by producing abnormal elastic-like material composed of degenerate fibrillar collagen, elastin, and fibronectin. On histopathology, this manifests as basophilic degeneration of subepithelial collagen with accumulation of irregular, curled, basophilic fibres that stain positively for elastin (elastic tissue stains such as Verhoeff or orcein). Unlike true elastic fibres, these deposits are resistant to elastase digestion — a hallmark feature distinguishing pinguecula from normal elastic tissue.
Matrix metalloproteinase (MMP) upregulation — UV-B activates MMP-1 (collagenase), MMP-2 and MMP-9 (gelatinases) in conjunctival fibroblasts and epithelial cells. These enzymes degrade normal stromal collagen, creating a permissive matrix for elastotic fibre accumulation. The resulting disorganised stroma forms the yellowish elevated mound characteristic of pinguecula.
p53 expression and cellular stress — elevated nuclear p53 expression has been identified in pinguecula epithelium, indicating that UV-induced DNA damage exceeds the repair capacity of affected cells. While p53 upregulation does not imply neoplasia in pinguecula, it suggests that the same mutagenic pathway that initiates CIN and squamous cell carcinoma is engaged, providing a mechanistic basis for the clinical caution to carefully monitor atypical-appearing lesions.
Pingueculitis mechanism — acute inflammatory episodes arise when additional environmental stimuli (acute UV exposure, tear film instability, wind, dust, or contact lens overwear) cause cytokine release (IL-1β, TNF-α), mast cell degranulation, and upregulation of ICAM-1 and VCAM-1 on vascular endothelium surrounding the pinguecula. This recruits neutrophils and mast cells, producing the perilesional vascular congestion and oedema of acute pingueculitis.
Tear film disruption — the elevated mound of a pinguecula distorts the overlying tear film meniscus, creating a zone of relative tear film thinning immediately adjacent to the lesion. This promotes a dellen (focal corneal or conjunctival desiccation dimple) at the limbus adjacent to the pinguecula and contributes to localised dry eye symptoms.
No universally adopted formal grading system for pinguecula has achieved the same currency as pterygium grading. Several descriptive frameworks are used clinically and in research.
Descriptive Classification by Activity
| Category | Features |
|---|---|
| Quiescent (inactive) | Yellowish-white, flat or slightly elevated, avascular or minimally vascular lesion; no surrounding injection; asymptomatic; most common presentation |
| Inflamed (pingueculitis) | Perilesional conjunctival injection and oedema; hyperaemia surrounding the lesion; associated with symptoms of irritation, redness, and foreign body sensation; triggered by UV, desiccation, or irritant exposure |
| Desiccated | Localised desiccation of the overlying epithelium; may show fine epithelial erosions or dellen formation adjacent to the lesion; associated with tear film break-up over the elevated mound |
Morphological Classification
- Flat (grade 1) — barely perceptible thickening of the conjunctival stroma; no clinically significant elevation
- Slightly elevated (grade 2) — visible mound formation; disrupts the tear film over its surface; nasal predominance; may be nasal, temporal, or bilateral
- Elevated and fleshy (grade 3) — pronounced nodular elevation; significant tear film disruption; may be associated with adjacent dellen; most likely to cause symptoms
Laterality
- Unilateral — single eye involvement; typically nasal
- Bilateral — common in patients with high cumulative UV exposure; bilateral nasal pingueculae are the most frequent bilateral pattern
- Bilateral symmetric — both nasal and temporal pingueculae may coexist in the same eye (four-point pinguecula pattern), particularly in elderly patients with high lifetime UV exposure
- Cumulative UV exposure — the single strongest modifiable risk factor; a dose-response relationship exists between lifetime UV exposure and pinguecula prevalence and severity. Singapore's equatorial UV index (typically 10–14, classified as Extreme) is among the highest globally, contributing to high local prevalence
- Advancing age — prevalence increases progressively with age; relatively uncommon below 30, common above 50. The Beijing Eye Study and Barbados Eye Study both reported strong age-related gradients
- Male sex — some epidemiological studies show slightly higher prevalence in males, attributed to greater outdoor occupational exposure; the sex difference narrows when recreational UV exposure is controlled for
- Tropical and subtropical residence — equatorial and near-equatorial geographic locations; the prevalence of pinguecula in Singapore and other equatorial countries is consistently higher than in temperate populations
- Outdoor occupation — farmers, fishermen, military personnel, construction workers, and sports coaches; studies in Singapore show higher prevalence in outdoor workers compared to indoor office workers
- Dry eye disease — reduced tear film stability accelerates ocular surface degeneration; pinguecula and dry eye commonly co-exist and mutually exacerbate each other
- Contact lens wear — chronic mechanical irritation and tear film disruption from contact lens use may predispose to or aggravate pinguecula
- Smoking — oxidative stress from cigarette smoke compounds UV-induced ocular surface damage
- Absence of UV-protective eyewear — lack of habitual sunglasses wear is an independent, modifiable risk factor supported by multiple population-based studies
Quiescent Pinguecula
- Location — nasal interpalpebral bulbar conjunctiva in the majority; temporal pinguecula is less common; bilateral nasal involvement common in older patients
- Colour — yellowish-white or cream-coloured; the yellow hue reflects lipid deposition and elastotic fibre accumulation within the stroma
- Elevation — flat to moderately elevated mound; well-demarcated borders; smooth surface with overlying conjunctival epithelium intact
- Vascularity — minimal intrinsic vascularity in the quiescent state; fine surface vessels may be present but without perilesional injection
- Position relative to cornea — adjacent to the limbus but does not cross it; this is the critical distinguishing sign from pterygium, where a fibrovascular head invades the corneal stroma
- Tear film meniscus disruption — visible on slit-lamp as an irregular tear film meniscus over and adjacent to the lesion; may be confirmed with fluorescein instillation and cobalt-blue filter
Pingueculitis (Inflamed Pinguecula)
- Marked perilesional conjunctival injection with dilated tortuous vessels surrounding the lesion
- Localised conjunctival oedema (chemosis) overlying and surrounding the pinguecula
- The pinguecula itself appears more prominent and oedematous
- Adjacent corneal dellen may be visible as a focal area of corneal thinning/desiccation at the limbus immediately adjacent to the lesion, best seen with fluorescein and cobalt-blue light
Advanced or Chronic Pinguecula
- Calcification — calcium deposits may appear as white chalky flecks within the lesion in long-standing cases
- Pigmentation — melanin pigmentation may occur in darker-skinned individuals, producing a brownish discolouration
- Epithelial surface irregularity — chronic desiccation may produce epithelial metaplasia or keratinisation of the lesion surface
The majority of pingueculae are entirely asymptomatic and discovered incidentally during routine ocular examination. When symptoms arise, they are typically related to ocular surface disruption or an acute episode of inflammation.
- Asymptomatic (most common) — incidental finding during routine slit-lamp examination; no visual impact; no patient-reported symptoms
- Cosmetic concern — patients may notice a yellowish or reddish spot on the white of the eye and present seeking reassurance or treatment on aesthetic grounds
- Dry eye symptoms — grittiness, sandiness, burning, foreign body sensation, and mild discomfort attributable to tear film irregularity over the elevated lesion; symptoms often worse in air-conditioned environments, with prolonged screen use, or in windy conditions — all of which are relevant to the Singapore indoor-outdoor work lifestyle
- Episodic ocular redness — recurrent episodes of localised or diffuse conjunctival redness, often misinterpreted by patients as allergy or infection
- Pingueculitis symptoms — acute onset of significant redness, irritation, tearing, and photophobia localised to the nasal or temporal quadrant; may be alarming to the patient who has not previously been informed of the pinguecula
- Contact lens intolerance — soft contact lens wearers may experience discomfort, lens decentration, or mucin ball formation related to tear film disruption adjacent to the pinguecula
- Visual symptoms — rare in true pinguecula; mild blur may occur from induced regular or irregular corneal astigmatism adjacent to the limbus if the elevated lesion is large; significant visual disturbance should prompt reassessment for early pterygium or an alternative diagnosis
- Pingueculitis — acute or recurrent inflammatory episodes; may be uncomfortable and cosmetically distressing; typically self-limiting but may require topical anti-inflammatory treatment
- Dellen formation — localised area of corneal or conjunctival desiccation immediately adjacent to the elevated pinguecula; caused by disruption of the tear film meniscus; appears as a focal corneal dimple or thinning; resolves with lubricating agents and elimination of the underlying cause
- Ocular surface disease and dry eye — chronic tear film instability due to the elevated lesion; may worsen pre-existing dry eye; disrupts the regular ocular surface required for optimal contact lens wear and LASIK candidacy assessment
- Progression to pterygium — a subset of pingueculae may progress to pterygium with corneal invasion; the clinical distinction between an advanced pinguecula and an early pterygium is not always sharp; regular monitoring is warranted in lesions approaching the limbus
- Calcification — calcium deposition within long-standing pingueculae can cause persistent ocular surface roughness and foreign body sensation; rarely significant clinically but may complicate surgical excision if undertaken
- Post-excision recurrence — excised pingueculae may recur, particularly if UV protective measures are not adopted post-operatively and in patients with ongoing UV or environmental exposure risk
- Post-operative complications — if surgical excision is performed, complications include conjunctival scarring, dellen, symblepharon (rare), and recurrence
- Delayed diagnosis of malignancy — while pinguecula itself is benign, over-reliance on a clinical pinguecula diagnosis without slit-lamp scrutiny may miss conjunctival intraepithelial neoplasia (CIN), primary acquired melanosis (PAM), or conjunctival melanoma in atypical lesions
Pinguecula is primarily a localised degenerative condition of the ocular surface with no direct systemic disease associations comparable to those seen in episcleritis or scleritis. However, several systemic and epidemiological considerations are relevant.
UV Exposure as a Shared Risk Factor
Chronic UV exposure — the primary driver of pinguecula — is also associated with cataract (cortical and posterior subcapsular types), age-related macular degeneration (AMD), and pterygium. Patients presenting with pinguecula at a young age or with bilateral, advanced, or progressive lesions should be counselled on their overall ocular UV exposure risk and the importance of comprehensive eye examination to screen for concurrent UV-related ocular conditions.
Dry Eye Disease
Pinguecula and dry eye disease (DED) share a strong bidirectional relationship. Tear film instability promotes pinguecula formation and inflammation; the elevated mound in turn worsens tear film stability and evaporative dry eye. Patients with autoimmune conditions associated with DED (Sjögren's syndrome, RA, thyroid eye disease) may present with more symptomatic pingueculae due to their baseline ocular surface compromise.
Metabolic and Lipid Associations
Some histochemical studies have identified lipid deposits (phospholipids, cholesterol esters) within pinguecula stroma in addition to elastotic fibres. A possible association between dyslipidaemia and pinguecula has been proposed in some series, though this remains inconsistent across studies and does not currently influence clinical investigation protocols.
Xeroderma Pigmentosum and DNA Repair Defects
Patients with xeroderma pigmentosum (XP) — a rare autosomal recessive DNA nucleotide excision repair disorder — develop severe UV-related ocular surface pathology at an accelerated rate, including pingueculae, pterygia, and conjunctival malignancies, often in childhood. XP serves as an extreme model of the UV-DNA damage pathway underlying pinguecula pathogenesis.
Clinical note: Pinguecula does not require systemic investigation in the vast majority of cases. If atypical features are present — rapid growth, pigmentation, irregular surface, ulceration, feeder vessel — conjunctival intraepithelial neoplasia or melanocytic lesions must be excluded with careful slit-lamp examination and, if indicated, photodocumentation and referral for biopsy.
Pinguecula is a clinical diagnosis based on characteristic slit-lamp findings. Ancillary investigations are rarely required for typical presentations but play an important role in excluding atypical or malignant mimics.
Slit-Lamp Biomicroscopy
- Diffuse illumination — survey lesion location, size, colour, elevation, and bilateral comparison
- Direct focal illumination — examine lesion morphology, surface regularity, intrinsic vascularity, and adjacent limbal architecture; confirm the lesion does not cross the limbus onto the cornea (pterygium exclusion)
- Sclerotic scatter — reveals subtle lesion boundaries and early corneal extension if present
- Fluorescein staining with cobalt-blue filter — identifies overlying epithelial staining (epithelial erosion), tear film break-up time (TBUT), and adjacent dellen formation; reduced TBUT adjacent to the pinguecula confirms tear film disruption
- Rose bengal or lissamine green staining — highlights devitalised conjunctival epithelial cells over and adjacent to the pinguecula; useful for quantifying ocular surface disease extent
- Broad tangential illumination — assesses elevation and calcification within the lesion
Documentation and Monitoring
- Anterior segment photography — baseline photodocumentation recommended for all pingueculae; essential for monitoring size, vascularity, and morphological changes at follow-up visits
- AS-OCT (anterior segment optical coherence tomography) — quantifies lesion elevation and thickness; maps the integrity of the adjacent limbal architecture; useful when the clinical distinction from early pterygium is uncertain
- Corneal topography — indicated if visual symptoms are present to detect induced limbal astigmatism; useful pre-operatively if excision is being considered
- Impression cytology — may be performed to assess conjunctival goblet cell density and epithelial integrity in research settings or where ocular surface disease severity warrants characterisation
Atypical Features Warranting Further Evaluation
- Rapid enlargement over weeks to months
- Pigmentation (brown, grey, or black discolouration) suggesting melanocytic activity
- Irregular, papillomatous, or gelatinous surface texture
- Dilated feeder vessels or sentinel vessels within the lesion
- Ulceration of the overlying epithelium
- Leukoplakia (white plaques) overlying the lesion
Any of the above features should prompt referral for conjunctival biopsy and histopathological assessment.
Singapore Optometry Scope Note: Optometrists in Singapore may manage quiescent and mildly symptomatic pingueculae independently — advising on preservative-free lubricants, UV protection, and environmental modification. Optometrists cannot prescribe topical steroids or topical NSAIDs; patients with pingueculitis or persistent symptoms requiring pharmacological treatment must be referred to an ophthalmologist or medical practitioner. Posterior segment assessment should be performed using approved diagnostic equipment (e.g., non-contact widefield fundus imaging or OCT); dilated fundus examination is not within the optometry scope of practice in Singapore. Refer to ophthalmology for atypical lesions, rapid growth, pigmented lesions, suspected corneal involvement, or surgical excision.
Conservative Management (First Line — Quiescent Pinguecula)
- Observation and reassurance — for asymptomatic lesions; explain the benign nature, UV aetiology, and monitoring plan; baseline photodocumentation
- UV-protective eyewear — cornerstone of prevention and prevention of progression; wrap-around sunglasses with UV400 certification and broad-brimmed hats; particularly important in Singapore given the extreme UV index year-round
- Preservative-free artificial tear lubricants — for symptomatic dry eye and foreign body sensation; sodium hyaluronate (0.1–0.3%) or carboxymethylcellulose (0.5–1%) drops 4–6 times daily; gel formulations or ointments at night for more significant desiccation symptoms
- Ocular surface optimisation — address concurrent dry eye disease, optimise contact lens wear schedules, reduce digital screen exposure without adequate blink management
- Environmental modification — reduce wind and dust exposure; use humidifiers in air-conditioned workplaces; protective eyewear in dusty or smoky environments
Pharmacological Management (Pingueculitis — Prescribed by Ophthalmologist or GP)
The following medications require a prescription and must be initiated by an ophthalmologist or medical practitioner. Optometrists in Singapore should refer patients with pingueculitis requiring pharmacological treatment.
- Topical NSAIDs — ketorolac tromethamine 0.5% QID or diclofenac sodium 0.1% QID for mild-to-moderate pingueculitis; reduces prostaglandin-mediated perilesional inflammation without the IOP risks associated with corticosteroids
- Topical corticosteroids (short course) — prednisolone acetate 0.5–1% or fluorometholone 0.1% QID for 1–2 weeks for moderate-to-severe pingueculitis not responding to NSAIDs; duration should be limited to minimise risk of steroid-induced IOP elevation and posterior subcapsular cataract; IOP should be monitored during any steroid course
- Vasoconstrictor drops — generally not recommended; may cause rebound hyperaemia and do not address the underlying inflammatory process
- Dellen management — intensive preservative-free lubricants within optometry scope; bandage soft contact lens fitting (within optometry scope) if an epithelial defect is significant; resolves once the underlying tear film disruption is corrected
Surgical Management
Surgical excision of a pinguecula is rarely indicated given the benign and typically asymptomatic nature of the condition. Indications include:
- Significant and persistent symptoms refractory to conservative and pharmacological management
- Cosmetically unacceptable appearance causing documented psychological distress
- Interference with contact lens fitting and wear
- Atypical lesion morphology requiring excision biopsy to exclude CIN or other conjunctival neoplasia
- Pre-LASIK or refractive surgery ocular surface optimisation
Surgical technique involves excision of the pinguecula with a thin margin of normal conjunctiva under local anaesthesia, followed by conjunctival autograft or amniotic membrane transplantation to reduce recurrence. Bare sclera excision has fallen out of favour due to unacceptably high recurrence rates. Adjunctive mitomycin C (MMC) is used by some surgeons to reduce recurrence, though MMC carries risks including scleral necrosis and should be used with caution.
The prognosis of pinguecula is excellent. The vast majority of pingueculae remain stable over decades, causing no visual impairment and requiring no specific treatment. Key prognostic considerations include:
- Stability — most quiescent pingueculae do not enlarge significantly over years to decades of follow-up; annual slit-lamp documentation allows objective assessment of any change
- Vision preservation — pinguecula does not directly threaten vision; visual acuity is unaffected in the vast majority of patients. The rare exception is a very large, elevated lesion inducing significant limbal astigmatism
- Recurrence after excision — recurrence rates after bare-sclera excision are reported as high as 20–30%; rates fall substantially to 5–10% with conjunctival autograft or amniotic membrane transplantation; ongoing UV protection remains the most important post-operative factor
- Progression to pterygium — a small minority of pingueculae progress to pterygium; risk factors for progression include younger age, higher UV exposure, larger lesion size, and the presence of limbal stem cell changes at the lesion margin
- Pingueculitis recurrence — acute inflammatory episodes typically resolve with treatment within days to two weeks but may recur, particularly without UV photoprotection and ocular surface management
- Quality of life — while most patients adapt well, those with repeated pingueculitis episodes, dry eye symptoms, or cosmetic concerns benefit significantly from structured management and counselling
| Condition | Key Distinguishing Features |
|---|---|
| Pterygium | Fibrovascular triangular tissue that crosses the limbus and invades the corneal stroma; has a distinct head (corneal component), neck, and body; corneal involvement causes astigmatism and visual symptoms; grows progressively onto the cornea |
| Conjunctival intraepithelial neoplasia (CIN) | Gelatinous, vascularised, or leukoplakic conjunctival lesion; typically at the limbus; may resemble pinguecula but with irregular surface, abnormal vessels, or pigmentation; requires biopsy for definitive diagnosis; IVCM or AS-OCT may assist |
| Conjunctival squamous cell carcinoma | Rapidly enlarging, papillomatous, or nodular conjunctival mass with feeder vessels; may ulcerate; any atypical conjunctival lesion growing rapidly warrants urgent ophthalmological referral and biopsy |
| Conjunctival melanoma | Pigmented (brown, grey, or rarely amelanotic) elevated conjunctival lesion; typically arising from primary acquired melanosis (PAM); irregular feeder vessels; urgent referral and biopsy mandatory |
| Primary acquired melanosis (PAM) | Flat, diffuse, brown conjunctival pigmentation at or near the limbus; unilateral; may transform to melanoma; requires regular photodocumentation and ophthalmological surveillance |
| Limbal dermoid | Solid, white-yellow elevated lesion at the inferotemporal limbus; present from birth or early childhood; contains ectopic tissue (hair follicles, sebaceous glands, fat); does not fluctuate with UV or inflammatory triggers |
| Conjunctival concretions | Multiple small, white-yellow, discrete calcium deposits in the palpebral conjunctiva (tarsal plate), not in the interpalpebral bulbar zone; may cause foreign body sensation when they erode through the epithelium |
| Episcleritis | Sectoral or diffuse redness without an elevated yellowish lesion; blanches with phenylephrine 2.5%; may be confused with inflamed pinguecula (pingueculitis) but lacks a discrete lesion at the limbus; typically painless |
| Lipid keratopathy (corneal arcus) | White ring of lipid deposition in the peripheral cornea (arcus senilis); intrastromal, not conjunctival; associated with hypercholesterolaemia in younger patients; does not form an elevated mound on the conjunctiva |
| Band keratopathy | Calcium deposition in Bowman layer in the interpalpebral corneal zone; grey-white horizontal band with Swiss-cheese appearance; corneal, not conjunctival; associated with chronic uveitis, hypercalcaemia, or gout |
- Always confirm the lesion does not cross the limbus. The single most important clinical step in differentiating pinguecula from pterygium is establishing whether the lesion is purely conjunctival or whether it has a corneal head. Use sclerotic scatter and fluorescein staining to map the limbal boundary precisely.
- Photodocumentation at every visit. Serial photography provides an objective record of stability or change and is the most reliable way to identify an otherwise imperceptible enlargement that might indicate a more sinister lesion.
- In Singapore, UV exposure counselling is a priority. Given the extreme UV index at equatorial latitudes, every patient with pinguecula should receive structured photoprotection advice: UV400 wrap-around sunglasses, broad-brimmed hats, and avoidance of peak UV hours (10 am–4 pm).
- Pingueculitis is often misdiagnosed as conjunctivitis. The absence of discharge, the localised perilesional pattern of injection, and the identifying presence of an underlying yellowish lesion distinguish pingueculitis from infective conjunctivitis. Antibiotic drops are not indicated for pingueculitis.
- Avoid vasoconstrictors. Topical vasoconstrictors (e.g., naphazoline, tetrahydrozoline) provide cosmetic whitening but cause rebound hyperaemia, can mask disease activity, and do not treat the underlying inflammation. They are not recommended in pinguecula management.
- Counsel patients on steroid risks when co-managing with a prescriber. If an ophthalmologist or GP has prescribed a short course of topical corticosteroids for pingueculitis, optometrists should monitor IOP at follow-up and flag any elevation, as even brief steroid courses carry risk of IOP elevation and posterior subcapsular cataract in susceptible individuals.
- Dellen management is simple but important. A dellen adjacent to a pinguecula can be confused with a corneal ulcer. The key differentiator is that a dellen is a smooth, non-inflammatory thinning that stains with fluorescein but has no stromal infiltrate. Intensive lubricants and removal of the desiccating stimulus lead to rapid resolution.
- Low threshold for referral if atypical. Any pinguecula-like lesion that is pigmented, rapidly growing, ulcerated, or associated with abnormal vessels should be referred to ophthalmology for excision biopsy and histopathological assessment to exclude CIN or melanocytic malignancy.
- Detorakis ET, Spandidos DA. Pathogenetic mechanisms and treatment options for ophthalmic pterygium: trends and perspectives (review). Int J Mol Med. 2009;23(4):439–47.
- Panchapakesan J, Hourihan F, Mitchell P. Prevalence of pterygium and pinguecula: the Blue Mountains Eye Study. Aust N Z J Ophthalmol. 1998;26 Suppl 1:S2–5.
- Luthra R, Nemesure BB, Wu SY, Leske MC; Barbados Eye Studies Group. Frequency and risk factors for pterygium in the Barbados Eye Study. Arch Ophthalmol. 2001;119(12):1827–32.
- Wong TY, Foster PJ, Johnson GJ, Seah SK, Tan DT. The prevalence and risk factors for pterygium in an adult Chinese population in Singapore: the Tanjong Pagar Survey. Am J Ophthalmol. 2001;131(2):176–83.
- Ooi JL, Sharma NS, Sharma S, Briggs N, Dawes JM, Khong CH, et al. Ultraviolet fluorescence photography to detect early sun damage in the anterior segment in a population of surf life savers. Am J Ophthalmol. 2006;141(1):22–30.
- Coroneo MT. Pterygium as an indicator of ultraviolet insolation: a hypothesis. Br J Ophthalmol. 1993;77(11):734–9.
- Chui J, Coroneo MT, Tat LT, Crouch R, Wakefield D, Di Girolamo N. Ophthalmic pterygium: a stem cell disorder with premalignant features. Am J Pathol. 2011;178(2):817–27.
- Tan DT, Lim AS, Goh HS, Smith DR. Abnormal expression of the p53 tumor suppressor gene in the conjunctiva of patients with pterygium. Am J Ophthalmol. 1997;123(3):404–5.
- Mackenzie FD, Hirst LW, Battistutta D, Green A. Risk analysis in the development of pterygia. Ophthalmology. 1992;99(7):1056–61.
- Shiroma H, Higa A, Sawaguchi S, Iwase A, Tomidokoro A, Amano S, et al. Prevalence and risk factors of pterygium in a southwestern island of Japan: the Kumejima Study. Am J Ophthalmol. 2009;148(5):766–71.
- Fotouhi A, Hashemi H, Khabazkhoob M, Mohammad K. Prevalence and risk factors of pterygium and pinguecula: the Tehran Eye Study. Eye (Lond). 2009;23(5):1125–9.
- Moran DJ, Hollows FC. Pterygium and ultraviolet radiation: a positive correlation. Br J Ophthalmol. 1984;68(5):343–6.
- Mimura T, Usui T, Obata H, Yamagami S, Mori M, Funatsu H, et al. Pinguecula and contact lenses. Eye (Lond). 2010;24(11):1685–91.
- Ang LP, Tan DT. Ocular surface squamous neoplasia. Curr Opin Ophthalmol. 2007;18(4):309–14.
- Stern ME, Beuerman RW, Fox RI, Gao J, Mircheff AK, Pflugfelder SC. The pathology of dry eye: the interaction between the ocular surface and lacrimal glands. Cornea. 1998;17(6):584–9.
- Siak JJ, Tong L, Wong WL, Cajucom-Uy H, Rosman M, Saw SM, et al. Prevalence and risk factors of pinguecula in Malay adults in Singapore: the Singapore Malay eye study. Ophthalmic Epidemiol. 2011;18(5):239–47.
- Cheng CL, Theng JT, Tan YH. Prevalence of pterygium and pinguecula in a Singaporean adult population. Singapore Med J. 2016;57(4):193–7.
- Keener GT. Pinguecula: its characteristics and pathology. Am J Ophthalmol. 1952;35(4):599–602.
- Jaros PA, DeLuise VP. Pingueculae and pterygia. Surv Ophthalmol. 1988;33(1):41–9.
- Dushku N, Reid TW. Immunohistochemical evidence that human pterygia originate from an invasion of vimentin-expressing altered limbal epithelial basal cells. Curr Eye Res. 1994;13(7):473–81.